glp-1 compounding is still in limbo. Will the FDA leave it for the next administration? Study Finds a Worrying searchfilter_slows gastric emptying Pack Size:Single Bottle (💚Good Deal: Save $30)

glp-1 compounding is still in limbo. Will the FDA leave it for the next administration? Study Finds a Worrying searchfilter_slows gastric emptying Pack Size:Single Bottle (💚Good Deal: Save $30)

Study Finds a Worrying New Side Effect of GLP-1 Drugs That No One's Talking About : ScienceAlert

Treatment of Apoe –/– Irs +/– mice (a mouse model of insulin resistance, metabolic syndrome, and atherosclerosis) with either lixisenatide or liraglutide decreased atherosclerotic lesion size, generated more stable plaques with fewer lesional leukocytes, and resulted in reduced necrotic cores and thicker fibrous caps (4)

searchfilter_slows gastric emptying

Pack Size:Single Bottle (💚Good Deal: Save $30)

[DOI] [PubMed] [Google Scholar] Watanabe T, Yaegashi H, Koizumi M, Toyota T, Takahashi T